These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 478382)

  • 1. [Myoclonic attacks induced by bromocriptine in Parkinsonian patients].
    Glaubman H; Rabey I; Vardi J
    Harefuah; 1979 Jan; 96(2):90-2. PubMed ID: 478382
    [No Abstract]   [Full Text] [Related]  

  • 2. Myoclonic attacks induced by L-dopa and bromocryptin in Parkinson patients: a sleep EEG study.
    Vardi J; Glaubman H; Rabey JM; Streifler M
    J Neurol; 1978 Apr; 218(1):35-42. PubMed ID: 77316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine in the treatment of parkinsonism.
    Parkes JD
    Drugs; 1979 May; 17(5):365-82. PubMed ID: 37066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-dopa induced "serotonin syndrome" in a parkinsonian patient on bromocriptine.
    Sandyk R
    J Clin Psychopharmacol; 1986 Jun; 6(3):194-5. PubMed ID: 3711372
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients.
    Serby M; Angrist B; Lieberman A
    Adv Biochem Psychopharmacol; 1980; 23():287-92. PubMed ID: 6104908
    [No Abstract]   [Full Text] [Related]  

  • 6. Bromocriptine in Parkinson's disease.
    Stern G; Lees A
    Br J Hosp Med; 1978 Dec; 20(6):666-70. PubMed ID: 743580
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bromocriptine].
    Raphael V
    Soins Gynecol Obstet Pueric Pediatr; 1989 Nov; (102):I-II. PubMed ID: 2617395
    [No Abstract]   [Full Text] [Related]  

  • 8. Bromocriptine:dopamine-receptor agonist.
    Dipalma JR
    Am Fam Physician; 1976 Dec; 14(6):88-9. PubMed ID: 1036662
    [No Abstract]   [Full Text] [Related]  

  • 9. [Letter: Effect of bromocryptine on the fluctuations following dopa therapy. On-off phenomenon in parkinsonian patients].
    Frattola L; Albizzati MG; Spano PF; Trabucchi M
    Nouv Presse Med; 1976 Aug 28-Sep 4; 5(28):1761. PubMed ID: 958891
    [No Abstract]   [Full Text] [Related]  

  • 10. Bromocriptine and lisuride in Parkinson disease.
    Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
    Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain dopamine receptor stimulation and the relief of Parkinsonism: relationship between bromocriptine and levodopa.
    Rinne UK; Marttila R
    Ann Neurol; 1978 Sep; 4(3):263-7. PubMed ID: 718139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bromocriptine in the treatment of patients with parkinsonism and dyskinesias induced by levodopa].
    Haas JA; Lakke JP
    Ned Tijdschr Geneeskd; 1982 Apr; 126(16):701-5. PubMed ID: 7088202
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experience with bromocriptine, a central dopaminergic stimulator].
    Ludin HP; Kunz F; Lörincz P; Ringwald E
    Nervenarzt; 1976 Nov; 47(11):651-5. PubMed ID: 794749
    [No Abstract]   [Full Text] [Related]  

  • 14. Bromocriptine.
    Sherman BM; Chapler FK
    J Iowa Med Soc; 1980 May; 70(5):209-10, 212. PubMed ID: 7189202
    [No Abstract]   [Full Text] [Related]  

  • 15. Bromocriptine - an important advance.
    Drug Ther Bull; 1976 Apr; 14(9):33-4. PubMed ID: 1278002
    [No Abstract]   [Full Text] [Related]  

  • 16. [The treatment of Parkinson disease using the combination bromocriptine and levodopa].
    Dufresne JJ
    Rev Med Suisse Romande; 1990 Jun; 110(6):559-64. PubMed ID: 2367793
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drugs and indications for medical treatment in Parkinson's disease (author's transl)].
    Allain H; Van den Driessche J; Menault F; Pape D; Reymann JM; Bentue-Ferrer D
    Sem Hop; 1980 Feb 8-15; 56(5-6):277-82. PubMed ID: 6243802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of bromocriptine given to de novo patients with idiopathic Parkinson's disease.
    Stern G; Lees A
    Adv Neurol; 1987; 45():525-7. PubMed ID: 3103395
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical studies with bromocriptine in idiopathic parkinsonism.
    Teychenne PF; Kartzinel R; Perlow M; Pfeiffer R; Calne DB
    Trans Am Neurol Assoc; 1976; 101():302-4. PubMed ID: 1037483
    [No Abstract]   [Full Text] [Related]  

  • 20. Further experiences with low doses of bromocriptine in Parkinson's disease.
    Fahn S; Côté LJ; Barrett RE; Snider SR
    Adv Biochem Psychopharmacol; 1980; 23():255-60. PubMed ID: 7395615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.